Article: BioVeris Licenses Exclusive Vaccine Rights From Baxter.

Staff Writer

Through a technology license agreement, BioVeris Corp. attained exclusive rights to a portfolio of vaccines that could someday enter billion dollar global infectious disease markets.

The Gaithersburg, Md.-based company signed for the rights from Baxter Healthcare Corp., agreeing to pay a license fee, and possibly patent costs and milestone fees, as well as royalties. The milestones would be based on the initiation and completion of clinical trials and regulatory approvals. A minimum annual royalty to Deerfield, Ill.-based Baxter would start in 2010, but it is creditable against any other milestone payments and royalties.

BioVeris ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!